Phenylphthalimides with tumor necrosis factor alpha production-enhancing activity

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 1, 1996, Pages 156-162

  Shibata, Yoshihiro ^a   Sasaki, Keizo ^a   Hashimoto, Yuichi ^a   Iwasaki, Shigeo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

phenylphthalimide; structure activity relationship; tumor necrosis factor alpha

Indexed keywords

2 (2,6 DIISOPROPYLPHENYL) 1H ISOINDOLE 1,3 DIONE; 2 (2,6 DIISOPROPYLPHENYL) 4 ,5,6,7 TETRAFLUORO 1H ISOINDOLE 1,3 DIONE; 2 (2,6 DIISOPROPYLPHENYL) 4 NITRO 1H ISOINDOLE 1,3 DIONE; 2 (2,6 DIISOPROPYLPHENYL) 5 NITRO 1H ISOINDOLE 1,3 DIONE; ANTINEOPLASTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; DRUG CONFORMATION; DRUG EFFECT; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN SYNTHESIS REGULATION; STRUCTURE ACTIVITY RELATION;

EID: 0030064197     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.156     Document Type: Article

References (31)

1. Carswell E. A., Old L. J., Kassel R. L., Green S., Foire N., Williamson B., Proc. Natl. Acad. Sci. U.S.A., 72, 3666-3670 (1975).
2. Sugarman B. J., Aggarawal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr., Shepard H. M., Science, 230, 419-426 (1989).
3. Bartsch H. H., Pfizenmaier K., Schroeder M., Nagel G. A., Eur. J. Cancer Clin. Oncol., 25, 287-291 (1989).
4. Pfreundschuh M. G., Steinmetz H. T., Tuschen R., Schenk V., Diehl V., Schaadt M., Eur J. Cancer Clin. Oncol., 25: 379-388 (1989).
5. Moritz T., Niederle N., Baumann J., May D., Kurschel E., Osiek R., Kempeni J., Schlick E., Schmidt C. G., Cancer Immunol. Immunother., 29, 144-150 (1989).
6. Rosenberg S A., Cancer Res., 51, 5074-1079 (1991)
7. Smith C. A., Farrah T., Goodwin R. G., Cell, 76, 959-962 (1994).
8. Sherry B., Cerami A., J. Cell Biol., 107, 1269-1277 (1988).
9. Debs R. J., Fuchs H. J., Philip R., Brunette E. N., Duzgunes N., Shellito J. E., Liggitt D., Patton J., Cancer Res., 50, 375-380 (1990).
10. Boussiotis V. A., Nadler L. M , Strominger J. L., Goldfeld A. E., Proc. Natl. Acad. Sci. U.S.A., 91, 7007-7011 (1994).
11. Manda T., Nishigaki F., Hemmi H., Ishida N., Cancer Res., 48, 4250-4255 (1988).
12. Komori A., Yatsunami J., Suganuma M., Okabe M., Abe A., Sakai A., Sasaki K., Fujiki H., Cancer Res., 53, 1982-1985 (1993).
13. D'Amato R J., Loughnan M. S., Flynn E., Folkman J., Proc Natl. Acad. Sci. U.S.A., 91, 4082-4085 (1994).
14. Makonkawkeyoon S., Limson-Pombre R. N. R., Moreira A. L., Schauf V., Kaplan G., Proc. Natl. Acad. Sci. U.S.A., 90, 5974-5978 (1993).
15. Shibata Y., Sasaki K., Hashimoto Y., Iwasaki S., Biochem. Biophys. Res. Commun., 205, 1992-1997 (1994).
16. Hashimoto Y., Chemistry Today, 283, 38-44 (1994).
17. Hashimoto Y., Farumasia, 30, 1276-1280 (1994).
18. Hashimoto Y., Kagaku To Seibutsu, 32, 604-608 (1994).
19. Hashimoto Y., Yakugaku Zasshi, 114, 357-373 (1994).
20. Noguchi K , Inagawa H., Tsuji Y., Morikawa A., Mizuno D., Soma G., J. Immunother., 10, 105-111 (1991).
21. Kelsey F. O., Teratology, 38, 221-226 (1988).
22. Sampio E. P., Sarno E. N., Galilly R., Cohn Z. A., Kaplan G., J. Exp. Med., 173, 699-703 (1991).
23. Randall T., J. Am. Med. Assoc., 263, 1467-1468 (1990).
24. Kaplan G., Immunobiology, 191, 564-568 (1994).
25. Feldmann R., Salomon D., Saurat J. H., Dermatology, 189, 425-427 (1994).
26. Siadak M., Sullivan K. M., Blood Rev., 8, 154-160 (1994).
27. Nishimura K., Hashimoto Y., Iwasaki S., Biochem. Biophys. Res. Commun., 199, 455-460 (1994).
28. Nishimura K., Hashimoto Y., Iwasaki S., Chem. Pharm. Bull., 42, 1157-1159 (1994).
29. Shibata Y., Shichita M., Sasaki K., Nishimura K., Hashimoto Y., Iwasaki S., Chem. Pharm. Bull., 43, 177-179 (1995).
30. Sasaki K., Shibata Y., Nishimura K , Hashimoto Y., Iwasaki S., Biol. Pharm. Bull., 17, 1313-1315 (1994).
31. Shibata Y., Sasaki K , Nishimura K., Hashimoto Y., Iwasaki S., Biol. Pharm. Bull., 17, 1532-1534 (1994).